We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$74M
Cap. Flow
-$42M
Cap. Flow %
-25.87%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$42M

Sector Composition

Rank Sector Weight
1 Healthcare 85.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.7B
$117M 72.07%
2,680,644
-885,243
-25% -$42M
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.3B
$24M 14.79%
738,500
– –
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.37B
$14.8M 9.09%
602,272
– –
YMAB
4
DELISTED
Y-mAbs Therapeutics
YMAB
$6.56M 4.04%
216,916
– –

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q1 2021 Portfolio in Review

As of Q1 2021, Memorial Sloan Kettering Cancer Center held 4 positions worth $162M, down 31% from $236M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Memorial Sloan Kettering Cancer Center withdrew a net $42M in Q1 2021, reducing 1 holding. Its largest reduction was Royalty Pharma, cutting an estimated $42M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 89% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $42M.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $162M portfolio in Q1 2021.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q1 2021.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 31% quarter-over-quarter to $162M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q1 2021, filed 17 May 2021.